Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening

M Guzmán-Blanco1, J M Casellas, H S Sader

  • 1Infectious Disease and Microbiology Unit, Hospital Vargas de Caracas, Venezuela.

Insights

Antibiotic resistance is a growing threat in Latin America, complicating infections. Enhanced surveillance is crucial for healthcare providers to combat rising bacterial resistance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Antibiotic resistance poses a significant threat to treating community- and hospital-acquired infections in Latin America.
  • Existing surveillance data may not be effectively reaching healthcare professionals, hindering timely interventions.
  • Specific challenges include penicillin-resistant meningococci and pneumococci, and ineffective oral antibiotics for urinary tract infections.

Purpose of the Study:

  • To highlight the escalating problem of antibiotic resistance in Latin America.
  • To underscore the need for improved information dissemination to healthcare providers.
  • To call for the establishment of an accessible antibiotic resistance surveillance network.

Main Methods:

  • Review of surveillance data and clinical reports on bacterial resistance patterns in Latin America.
  • Analysis of resistance trends for key pathogens like Neisseria meningitidis, Streptococcus pneumoniae, Klebsiella pneumoniae, Pseudomonas aeruginosa, Acinetobacter baumannii, Staphylococcus aureus, and Enterococci.
  • Identification of specific antibiotic resistance challenges in community- and hospital-acquired infections.

Main Results:

  • Increased resistance to penicillin in meningococci and pneumococci.
  • Diminished efficacy of common oral antibiotics for community-acquired urinary tract infections.
  • Rising prevalence of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in ICUs.
  • Emergence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci.

Conclusions:

  • Antibiotic resistance is a critical and growing public health concern in Latin America.
  • There is an urgent need for a readily accessible surveillance network for antibiotic prescribing healthcare professionals in the region.
  • Effective strategies are required to combat the spread of resistant bacteria and ensure favorable infection outcomes.

Related Concept Videos

Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Antibiotic Selection01:45

Antibiotic Selection

Researchers use antibiotic resistance genes to identify bacteria that possess a plasmid containing their gene of interest. Antibiotic resistance naturally occurs when a spontaneous DNA mutation creates changes in bacterial genes that eliminate antibiotic activity. Bacteria can share these new resistance genes with their offspring and other bacteria. The overuse and misuse of antibiotics have created a public health crisis, as resistant and multi-resistant bacteria continue to develop.Antibiotic...
Microbiota Modulation by Antibiotics01:21

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...